In this study we assess the representativeness of the monitoring programmes of three swine diseases: PRRS (porcine reproductive and respiratory syndrome), AD (Aujeszky's disease) and TGE (transmissible gastroenteritis).How many of the farms are covered by the monitoring programmes annually, and is the sampling unbiased?What is the likelihood of detection with an unknown amount of positive farms in Finland?Is the monitoring carried out during 2008-2009 sufficient to show that the population covered by the monitoring remained disease-free.
A nationwide seroepidemiological study was conducted to estimate the prevalence of Toxoplasma gondii in selected wild and domestic ruminants in Finland. Serum samples from 1367 game cervids collected during the hunting season in 2008–2009 and 1940 sheep sera collected in 2008 were screened with a commercial direct agglutination test at a serum dilution of 1:40. T. gondii-specific IgG antibodies were detected in 116 (9.6%) of 1215 moose (European elk, Alces alces), 36 (26.7%) of 135 white-tailed deer (Odocoileus virginianus), 3 (17.6%) of 17 roe deer (Capreolus capreolus), and 477 (24.6%) of 1940 domestic sheep. Seropositive sheep were found in 74 (76.3%) of the 97 flocks examined. The odds of seropositivity in the adult moose was 2.9 times higher than the odds in calves; in white-tailed deer, the odds ratio was 3.2. The male moose had a significantly lower seroprevalence than the female, whereas the seroprevalence in the male white-tailed deer was higher than in the female; the odds ratios were 0.6 and 2.5, respectively. A clear geographical gradient in the seroprevalence was revealed in moose and sheep. The seroprevalences were lowest (1.6 and 8.6%, respectively) in the north and highest (24.6 and 36.4%, respectively) in the south-western regions, and ranged between these values in the other regions. In fact, the seroprevalence in moose from the south-west was not significantly different from the prevalence in white-tailed deer from the same area. Thus, the Finnish wild cervids and sheep are commonly exposed to T. gondii, especially in the southern part of the country.
Bovine acute phase proteins (APPs), lipopolysaccharide binding protein (LBP), serum amyloid A (SAA), haptoglobin (Hp) and alpha(1)-acid glycoprotein (AGP) were evaluated as inflammatory markers during an outbreak of bovine respiratory disease (BRD) caused by bovine respiratory syncytial virus (BRSV). Calves (n = 10) presented mild to moderate signs of respiratory disease. Secondary bacterial infections, Pasteurella multocida and Mycoplasma dispar as major species, were detected in tracheobronchial lavage samples. Concentrations of SAA and LBP increased at week 1 had the highest values at week 3 and decreased at week 4 of outbreak. Some calves had high Hp concentrations at week 3, but AGP concentrations did not rise during respiratory disease. Higher SAA, LBP and Hp concentrations at a later stage of BRD (week 3) were associated with the low BRSV-specific IgG(1) production, suggesting that these calves had enhanced inflammatory response to the secondary bacterial infection. In conclusion, APPs (especially SAA and LBP) are sensitive markers of respiratory infection, and they may be useful to explore host response to the respiratory infections in clinical research.
Official vaccine sales statistics, the development of the young dog population and the takes of available vaccines were used to calculate the vaccine coverage and herd immunity (HI) against canine distemper, endemic during 1990–1993 and epidemic in 1994–1995 in Finland. Despite the satisfactory vaccine coverage, HI was no more than 50–65% in 1990–1993 because low-take vaccines dominated the market. Replacement of the low-take with high-take vaccines in 1995 raised the HI to 90%, which coincided with the ending of the epidemic. In 1996, the HI was slightly above 70%, which was sufficient to control the disease despite infectious pressure caused by repeated imports.